Custom Antibody Market

Custom Antibody Market by Service (Antibody Production, Characterization, Immunization, Fragmentation), Type (Monoclonal, Polyclonal, Recombinant), Source (Mouse, Rabbit), Research Area (Oncology, Immunology), and End Users - Global Forecast to 2023

Report Code: BT 6817 Dec, 2018, by marketsandmarkets.com

[198 Pages Report] The global custom antibody market is projected to reach USD 481 million by 2023 from USD 313 million in 2018, at a CAGR of 8.9%. The growth of this market is mainly driven by the increase in research activities in the life sciences industry, growing industry-academia collaborations, expanding antibody therapeutics pipeline, and the growing quality concerns over catalog antibodies that are driving the end users towards custom-made antibodies.

Custom Antibody Market

The antibody development segment is expected to account for the largest share of the custom antibody market in 2018

Based on service, the market is segmented into antibody development, antibody production & purification, and antibody fragmentation & labeling. The antibody development segment is further subsegmented into antigen preparation, immunization & hybridoma production, and antibody characterization. Antibody development services accounted for the largest share of the market in 2017. The large share of this segment can be attributed to the increasing focus of researchers on high-quality antibodies for reproducibility, which can be hampered by using commercially available antibodies.

Owing to ease of production, the monoclonal antibodies segment is expected to account for the largest share of the custom antibody market in 2018

Based on type, custom antibodies are categorized as monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and other custom antibodies. The monoclonal antibodies segment is estimated to account for the largest market share in 2018 as monoclonal antibodies provide high specificity and selectivity compared to other antibodies and are thus the preferred choice in all types of research studies.

By source, the mice segment is expected to account for the largest share of the custom antibody market in 2018

On the basis of source, the market has been segmented into mice, rabbits, and other sources. The mice segment is estimated to account for the largest share of the market in 2018. Mice are the most preferred hosts for research-use antibody production. Compared to other experimental animals, mice offer advantages of lower feeding costs and ease of maintenance & handling due to their small size, thus accounting for the largest share of the market.

The oncology segment is expected to account for the largest share of the custom antibody market in 2018

Based on the area of research, the market is segmented into oncology, infectious diseases, neurobiology, stem cells, immunology, cardiovascular disease, and other research areas. The oncology segment is estimated to account for the largest share of the custom antibodies market in 2018. This large share is attributed to the fact that cancer is one of the leading causes of death worldwide, which has driven the focus on its early detection and treatment.

The pharmaceutical & biotechnology companies segment is expected to account for the largest share of the custom antibody market in 2018

Based on end users, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations. The pharmaceutical & biotechnology companies segment is estimated to hold the largest share of the market in 2018. The large share of this segment is attributed to the increasing demand for high-specificity antibodies for drug discovery and development, increasing research in the areas of genomics and proteomics, and the need for antibodies in the identification of new targets and assays.

Custom Antibody Market

The APAC region is expected to grow at the highest CAGR during the forecast period

The custom antibody market in the APAC is expected to grow at the highest CAGR during the forecast period. The expanding pharmaceutical industry in China and India (the fastest growing markets) and the increasing investments in life science research in these countries are factors driving the growth of the APAC market. Also, growing proteomics and genomics research and increasing research funding, increasing investments by pharmaceutical and biotechnology companies, growing awareness about personalized therapeutics, and increasing research activities in the field of mAb-based therapeutics are driving the growth of this regional segment.

Key Market Players 

The prominent players in the global custom antibody market are Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck Group (Germany), Abcam plc (UK), Cell Signaling Technology, Inc. (US), Agilent Technologies, Inc. (US), GenScript (US), BioLegend, Inc. (US), Rockland Immunochemicals (US), ProMab Biotechnologies (US), Innovagen AB (Sweden), and ProteoGenix (US).

Thermo Fisher Scientific

Thermo Fisher Scientific is one of the leading players in the custom antibody market in 2017. The company is known for its diversified product offerings in the antibodies arena along with a wide range of customization services ranging from antigen preparation to antibody characterization and labeling. Owing to its strong sales and distribution network, the company has a significant global footprint. Additionally, having a large number of production sites gives it a competitive advantage over other players in the custom antibodies market.

GenScript

GenScript has established itself as one of the leading players in the custom antibodies market with a wide portfolio of services ranging from monoclonal and polyclonal antibody development to antibody conjugation, peptide synthesis, and antibody labeling. The company operates through a direct sales network in over 100 countries in North America, Europe, and Asia Pacific catering to pharmaceutical and biotech companies, colleges and universities, research institutes, and government bodies (including government testing and diagnostic centers).

Recent Developments

  • In 2018, Abcam launched the (PBS)-only recombinant antibodies and the new anti-PD-L1 antibody clone MKP1A07310 (clone 73-10) developed in collaboration with Merck KGaA (Germany).
  • In 2017, GenScript launched a new custom rabbit monoclonal antibody (mAb) service—MonoRab as part of the integrated premium antibody service portfolio.
  • In 2016, Thermo Fisher acquired Affymetrix, a provider of cellular and genetic analysis products. The acquisition helped Thermo Fisher expand its research antibody portfolio and strengthen its leadership in the biosciences business. It also helped add new genetic analysis capabilities in the clinical and applied markets.

Critical questions the report answers:

  • Where will all these developments take the industry in the medium to long-term?
  • What are the major end users of custom antibody services market?
  • What are the research areas of the custom antibody market?
  • Which are the major custom antibody services?
  • Which geographies are likely to grow at the highest CAGR?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Custom Antibody Market: Introduction (Page No. - 18)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Stakeholders
    1.6 Limitations

2 Custom Antibody Market: Research Methodology (Page No. - 22)
    2.1 Research Approach
           2.1.1 Secondary Research
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Research
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Break Down of Primaries
                    2.1.2.3 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Data Triangulation Approach
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Custom Antibody Market: Executive Summary (Page No. - 31)

4 Custom Antibody Market: Premium Insights (Page No. - 36)
    4.1 Custom Antibod Market: Overview
    4.2 Custom Antibodies Market: Geographic Growth Opportunities
    4.3 Regional Mix: Custom Antibodies Market (2018–2023)
    4.4 Custom Antibodies Market: Developed vs Developing Markets, 2018 vs 2023

5 Custom Antibody Market: Overview (Page No. - 40)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Increasing Research Activity and Funding
                    5.2.1.2 Quality Concerns Over Catalog Antibodies
                    5.2.1.3 Increasing Antibody Therapeutics and Expanding Drug Pipeline
                    5.2.1.4 Growing Industry-Academia Collaborations
           5.2.2 Market Opportunities
                    5.2.2.1 High Growth Opportunities in Emerging Countries
                    5.2.2.2 Increasing Demand for Personalized Medicine and Protein Therapeutics
                    5.2.2.3 Growth in Stem Cell and Cvd Research
                    5.2.2.4 Increasing Focus on Biomarker Discovery
           5.2.3 Market Challenges
                    5.2.3.1 Cost- and Time-Intensive Antibody Development Processes
                    5.2.3.2 Presence of Antibody Alternatives
           5.2.4 Industry Trends
                    5.2.4.1 Increasing Focus on Antibody-Drug Conjugates (ADCS)
                    5.2.4.2 Development of Bispecific Antibodies

6 Custom Antibody Market, By Service (Page No. - 51)
    6.1 Introduction
    6.2 Antibody Development
           6.2.1 Antibody Characterization
                    6.2.1.1 Characterization Eliminates Antibodies With Heterogeneities That May Hamper Research Studies; This is Driving Market Growth
           6.2.2 Antigen Preparation
                    6.2.2.1 Antigen Preparation Forms One of the Most Important Steps in the Antibody Production Process
           6.2.3 Immunization & Hybridoma Production
                    6.2.3.1 Specific Immunization Protocols are Followed Depending on the Antibody Required and Animal Used to Generate Them
    6.3 Antibody Production & Purification
    6.4 Antibody Fragmentation & Labeling

7 Custom Antibody Market, By Type (Page No. - 61)
    7.1 Introduction
    7.2 Monoclonal Antibodies
           7.2.1 Monoclonal Antibodies to Dominate the Market During the Forecast Period
    7.3 Polyclonal Antibodies
           7.3.1 Polyclonal Abs are Preferred in Proteomic Research for Detection of Denatured Proteins
    7.4 Recombinant Antibodies
           7.4.1 Research Reproducibility Offered By These Antibodies is Driving the Growth of the Recombinant Antibodies Segment
    7.5 Other Custom Antibodies

8 Custom Antibody Market, By Source (Page No. - 69)
    8.1 Introduction
    8.2 Mice
           8.2.1 Mice are the Most Preferred Hosts for Monoclonal Antibody Production
    8.3 Rabbits
           8.3.1 Antibodies Developed in Rabbits Eliminate the Limitation of Self-Antigen Recognition in Humans
    8.4 Other Sources

9 Custom Antibody Market, By Research Area (Page No. - 74)
    9.1 Introduction
    9.2 Oncology
           9.2.1 Use of Antibodies has Grown Considerably in Cancer Research
    9.3 Infectious Diseases
           9.3.1 Antibodies are Widely Used in R&D for the Development of Vaccines & Therapeutics Against Various Infectious Diseases
    9.4 Immunology
           9.4.1 Assessment of Cell Surface Antigens Using Antibodies Forms an Important Field of Research in Immunology
    9.5 Neurobiology
           9.5.1 Neurobiology Forms One of the Fastest-Growing Segments in Terms of Research Being Undertaken Utilizing Antibodies
    9.6 Stem Cells
           9.6.1 Availability of High-Quality Antibodies has Boosted Stem Cell Research
    9.7 Cardiovascular Diseases
           9.7.1 Identification & Characterization of Cvd Biomarkers is an Important Research Area Utilizing Antibodies
    9.8 Other Research Areas

10 Custom Antibody Market, By End User (Page No. - 85)
     10.1 Introduction
     10.2 Pharmaceutical & Biotechnology Companies
             10.2.1 Pharmaceutical & Biotechnology Companies are the Largest End Users of Custom Antibodies
     10.3 Academic & Research Institutes
             10.3.1 Increase in DNA Sequencing Studies and Proteomic Research to Drive Market Growth
     10.4 Contract Research Organizations
             10.4.1 Cros Provide Affordable Outlets for Companies and Academia to Pursue New Medicines and Offer A Cost-Effective Solution to Develop Drugs

11 Custom Antibody Market, By Region (Page No. - 92)
     11.1 Introduction
     11.2 North America
             11.2.1 Us
                        11.2.1.1 Growing Research in the Field of Structure-Based Drug Design and Therapeutic Mabs to Drive Market Growth
             11.2.2 Canada
                        11.2.2.1 Increasing Genomic Research to Drive the Adoption of Custom Antibodies in the Coming Years
     11.3 Europe
             11.3.1 Germany
                        11.3.1.1 High Investments for the Development of ADCS Support the Growth of the Custom Antibodies Market in Germany
             11.3.2 Uk
                        11.3.2.1 Growing Research Investments to Drive Growth in the Life Science Research Market, Resulting in the Growing Use of Antibodies
             11.3.3 France
                        11.3.3.1 Expanding Pipeline of Therapeutic Mabs Along With Increasing Investments in Research are Supporting Market Growth
             11.3.4 Italy
                        11.3.4.1 Growing Proteomics and Genomics Research at the Academic Level to Play A Key Role in Market Growth in Italy
             11.3.5 Spain
                        11.3.5.1 Increasing Focus on the Advancement of Translational Personalized Medicine is Expected to Drive Market Growth
             11.3.6 Rest of Europe
     11.4 Asia Pacific
             11.4.1 Japan
                        11.4.1.1 Large Number of Research Initiatives Towards the Development of Various ADCS Support Market Growth in Japan
             11.4.2 China
                        11.4.2.1 China is One of the Fastest-Growing Markets in the Research Sector and is Expected to Dominate the Market in the Coming Years
             11.4.3 India
                        11.4.3.1 Research for Generic Mabs and Fusion Mabs as Therapeutics is Expected to Propel the Custom Antibodies Market in the Country
             11.4.4 Rest of Asia Pacific
     11.5 Latin America
             11.5.1 Increasing Applications of Research-Specific Custom Antibodies to Drive the Growth of the Market in the Region
     11.6 Middle East & Africa
             11.6.1 Growing Focus of Pharmaceutical Companies on the African Market is Driving the Market for Custom Antibodies in the Region

12 Custom Antibody Market: Competitive Landscape (Page No. - 153)
     12.1 Overview
     12.2 Market Share Analysis
     12.3 Competitive Situation and Trends
             12.3.1 Product & Services Launches
             12.3.2 Expansions
             12.3.3 Acquisitions
             12.3.4 Other Strategies

13 Company Profiles (Page No. - 159)
(Business Overview, Services Offered, Recent Developments, SWOT Analysis, MnM View)*
     13.1 Thermo Fisher Scientific Inc.
     13.2 Genscript
     13.3 Abcam PLC
     13.4 Merck Group
     13.5 Bio-Rad Laboratories, Inc.
     13.6 Cell Signaling Technology, Inc.
     13.7 Agilent Technologies, Inc.
     13.8 Biolegend, Inc.
     13.9 Rockland Immunochemicals Inc.
     13.10 Promab Biotechnologies, Inc.
     13.11 Proteogenix
     13.12 Innovagen Ab

*Business Overview, Services Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 190)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.4 Available Customizations
     14.5 Related Reports
     14.6 Author Details


List of Tables (143 Tables)

Table 1 Market Drivers: Impact Analysis
Table 2 Market Opportunities: Impact Analysis
Table 3 Market Challenges: Impact Analysis
Table 4 Custom Antibody Market, By Service, 2016–2023 (USD Million)
Table 5 Antibody Development Market, By Type, 2016–2023 (USD Million)
Table 6 Antibody Development Market, By Country, 2016–2023 (USD Million)
Table 7 Antibody Characterization Market, By Country, 2016–2023 (USD Million)
Table 8 Antigen Preparation Market, By Country, 2016–2023 (USD Million)
Table 9 Immunization & Hybridoma Production Market, By Country, 2016–2023 (USD Million)
Table 10 Antibody Production & Purification Market, By Country, 2016–2023 (USD Million)
Table 11 Antibody Fragmentation & Labeling Market, By Country, 2016–2023 (USD Million)
Table 12 Custom Antibody Market, By Type, 2016–2023 (USD Million)
Table 13 Custom Monoclonal Antibodies Market, By Country, 2016–2023 (USD Million)
Table 14 Custom Polyclonal Antibodies Market, By Country, 2016–2023 (USD Million)
Table 15 Custom Recombinant Antibodies Market, By Country, 2016–2023 (USD Million)
Table 16 Other Custom Antibodies Market, By Country, 2016–2023 (USD Million)
Table 17 Custom Antibodies Market, By Source, 2016–2023 (USD Million)
Table 18 Custom Antibodies Market for Mice, By Country, 2016–2023 (USD Million)
Table 19 Custom Antibodies Market for Rabbits, By Country, 2016–2023 (USD Million)
Table 20 Custom Antibodies Market for Other Sources, By Country, 2016–2023 (USD Million)
Table 21 Custom Antibodies Market, By Research Area, 2016–2023 (USD Million)
Table 22 Custom Antibodies Market for Oncology, By Country, 2016–2023 (USD Million)
Table 23 Custom Antibodies Market for Infectious Diseases, By Country, 2016–2023 (USD Million)
Table 24 Custom Antibodies Market for Immunology, By Country, 2016–2023 (USD Million)
Table 25 Custom Antibodies Market for Neurobiology, By Country, 2016–2023 (USD Million)
Table 26 Custom Antibodies Market for Stem Cells, By Country, 2016–2023 (USD Million)
Table 27 Custom Antibodies Market for Cardiovascular Diseases, By Country, 2016–2023 (USD Million)
Table 28 Custom Antibodies Market for Other Research Areas, By Country, 2016–2023 (USD Million)
Table 29 Custom Antibodies Market, By End User, 2016–2023 (USD Million)
Table 30 Custom Antibodies Market for Pharmaceutical & Biotechnology Companies, By Country, 2016–2023 (USD Million)
Table 31 Custom Antibodies Market for Academic & Research Institutes, By Country, 2016–2023 (USD Million)
Table 32 Custom Antibodies Market for Contract Research Organizations, By Country, 2016–2023 (USD Million)
Table 33 Custom Antibodies Market, By Region, 2016–2023 (USD Million)
Table 34 North America: Custom Antibody Market, By Country, 2016–2023 (USD Million)
Table 35 North America: Custom Antibodies Market, By Service, 2016–2023 (USD Million)
Table 36 North America: Antibody Development Market, By Type, 2016–2023 (USD Million)
Table 37 North America: Custom Antibodies Market, By Type, 2016–2023 (USD Million)
Table 38 North America: Custom Antibodies Market, By Source, 2016–2023 (USD Million)
Table 39 North America: Custom Antibodies Market, By Research Area, 2016–2023 (USD Million)
Table 40 North America: Custom Antibodies Market, By End User, 2016–2023 (USD Million)
Table 41 US: Custom Antibody Market, By Service, 2016–2023 (USD Million)
Table 42 US: Antibody Development Market, By Type, 2016–2023 (USD Million)
Table 43 US: Custom Antibodies Market, By Type, 2016–2023 (USD Million)
Table 44 US: Custom Antibodies Market, By Source, 2016–2023 (USD Million)
Table 45 US: Custom Antibodies Market, By Research Area, 2016–2023 (USD Million)
Table 46 US: Custom Antibodies Market, By End User, 2016–2023 (USD Million)
Table 47 Canada: Custom Antibody Market, By Service, 2016–2023 (USD Million)
Table 48 Canada: Antibody Development Market, By Type, 2016–2023 (USD Million)
Table 49 Canada: Custom Antibodies Market, By Type, 2016–2023 (USD Million)
Table 50 Canada: Custom Antibodies Market, By Source, 2016–2023 (USD Million)
Table 51 Canada: Custom Antibodies Market, By Research Area, 2016–2023 (USD Million)
Table 52 Canada: Custom Antibodies Market, By End User, 2016–2023 (USD Million)
Table 53 Europe: Custom Antibody Market, By Country, 2016–2023 (USD Million)
Table 54 Europe: Custom Antibodies Market, By Service, 2016–2023 (USD Million)
Table 55 Europe: Antibody Development Market, By Type, 2016–2023 (USD Million)
Table 56 Europe: Custom Antibodies Market, By Type, 2016–2023 (USD Million)
Table 57 Europe: Custom Antibodies Market, By Source, 2016–2023 (USD Million)
Table 58 Europe: Custom Antibodies Market, By Research Area, 2016–2023 (USD Million)
Table 59 Europe: Custom Antibodies Market, By End User, 2016–2023 (USD Million)
Table 60 Germany: Custom Antibody Market, By Service, 2016–2023 (USD Million)
Table 61 Germany: Antibody Development Market, By Type, 2016–2023 (USD Million)
Table 62 Germany: Custom Antibodies Market, By Type, 2016–2023 (USD Million)
Table 63 Germany: Custom Antibodies Market, By Source, 2016–2023 (USD Million)
Table 64 Germany: Custom Antibodies Market, By Research Area, 2016–2023 (USD Million)
Table 65 Germany: Custom Antibodies Market, By End User, 2016–2023 (USD Million)
Table 66 UK: Custom Antibody Market, By Service, 2016–2023 (USD Million)
Table 67 UK: Antibody Development Market, By Type, 2016–2023 (USD Million)
Table 68 UK: Custom Antibodies Market, By Type, 2016–2023 (USD Million)
Table 69 UK: Custom Antibodies Market, By Source, 2016–2023 (USD Million)
Table 70 UK: Custom Antibodies Market, By Research Area, 2016–2023 (USD Million)
Table 71 UK: Custom Antibodies Market, By End User, 2016–2023 (USD Million)
Table 72 France: Custom Antibody Market, By Service, 2016–2023 (USD Million)
Table 73 France: Antibody Development Market, By Type, 2016–2023 (USD Million)
Table 74 France: Custom Antibodies Market, By Type, 2016–2023 (USD Million)
Table 75 France: Custom Antibodies Market, By Source, 2016–2023 (USD Million)
Table 76 France: Custom Antibodies Market, By Research Area, 2016–2023 (USD Million)
Table 77 France: Custom Antibodies Market, By End User, 2016–2023 (USD Million)
Table 78 Italy: Custom Antibody Market, By Service, 2016–2023 (USD Million)
Table 79 Italy: Antibody Development Market, By Type, 2016–2023 (USD Million)
Table 80 Italy: Custom Antibodies Market, By Type, 2016–2023 (USD Million)
Table 81 Italy: Custom Antibodies Market, By Source, 2016–2023 (USD Million)
Table 82 Italy: Custom Antibodies Market, By Research Area, 2016–2023 (USD Million)
Table 83 Italy: Custom Antibodies Market, By End User, 2016–2023 (USD Million)
Table 84 Spain: Custom Antibody Market, By Service, 2016–2023 (USD Million)
Table 85 Spain: Antibody Development Market, By Type, 2016–2023 (USD Million)
Table 86 Spain: Custom Antibodies Market, By Type, 2016–2023 (USD Million)
Table 87 Spain: Custom Antibodies Market, By Source, 2016–2023 (USD Million)
Table 88 Spain: Custom Antibodies Market, By Research Area, 2016–2023 (USD Million)
Table 89 Spain: Custom Antibodies Market, By End User, 2016–2023 (USD Million)
Table 90 RoE: Custom Antibody Market, By Service, 2016–2023 (USD Million)
Table 91 RoE: Antibody Development Market, By Type, 2016–2023 (USD Million)
Table 92 RoE: Custom Antibodies Market, By Type, 2016–2023 (USD Million)
Table 93 RoE: Custom Antibodies Market, By Source, 2016–2023 (USD Million)
Table 94 RoE: Custom Antibodies Market, By Research Area, 2016–2023 (USD Million)
Table 95 RoE: Custom Antibodies Market, By End User, 2016–2023 (USD Million)
Table 96 Asia Pacific: Custom Antibody Market, By Country, 2016–2023 (USD Million)
Table 97 Asia Pacific: Custom Antibodies Market, By Service, 2016–2023 (USD Million)
Table 98 Asia Pacific: Antibody Development Market, By Type, 2016–2023 (USD Million)
Table 99 Asia Pacific: Custom Antibodies Market, By Type, 2016–2023 (USD Million)
Table 100 Asia Pacific: Custom Antibodies Market, By Source, 2016–2023 (USD Million)
Table 101 Asia Pacific: Custom Antibodies Market, By Research Area, 2016–2023 (USD Million)
Table 102 Asia Pacific: Custom Antibodies Market, By End User, 2016–2023 (USD Million)
Table 103 Japan: Custom Antibody Market, By Service, 2016–2023 (USD Million)
Table 104 Japan: Antibody Development Market, By Type, 2016–2023 (USD Million)
Table 105 Japan: Custom Antibodies Market, By Type, 2016–2023 (USD Million)
Table 106 Japan: Custom Antibodies Market, By Source, 2016–2023 (USD Million)
Table 107 Japan: Custom Antibodies Market, By Research Area, 2016–2023 (USD Million)
Table 108 Japan: Custom Antibodies Market, By End User, 2016–2023 (USD Million)
Table 109 China: Custom Antibody Market, By Service, 2016–2023 (USD Million)
Table 110 China: Antibody Development Market, By Type, 2016–2023 (USD Million)
Table 111 China: Custom Antibodies Market, By Type, 2016–2023 (USD Million)
Table 112 China: Custom Antibodies Market, By Source, 2016–2023 (USD Million)
Table 113 China: Custom Antibodies Market, By Research Area, 2016–2023 (USD Million)
Table 114 China: Custom Antibodies Market, By End User, 2016–2023 (USD Million)
Table 115 India: Custom Antibody Market, By Service, 2016–2023 (USD Million)
Table 116 India: Antibody Development Market, By Type, 2016–2023 (USD Million)
Table 117 India: Custom Antibodies Market, By Type, 2016–2023 (USD Million)
Table 118 India: Custom Antibodies Market, By Source, 2016–2023 (USD Million)
Table 119 India: Custom Antibodies Market, By Research Area, 2016–2023 (USD Million)
Table 120 India: Custom Antibodies Market, By End User, 2016–2023 (USD Million)
Table 121 RoAPAC: Custom Antibody Market, By Service, 2016–2023 (USD Million)
Table 122 RoAPAC: Antibody Development Market, By Type, 2016–2023 (USD Million)
Table 123 RoAPAC: Custom Antibodies Market, By Type, 2016–2023 (USD Million)
Table 124 RoAPAC: Custom Antibodies Market, By Source, 2016–2023 (USD Million)
Table 125 RoAPAC: Custom Antibodies Market, By Research Area, 2016–2023 (USD Million)
Table 126 RoAPAC: Custom Antibodies Market, By End User, 2016–2023 (USD Million)
Table 127 Latin America: Custom Antibody Market, By Service, 2016–2023 (USD Million)
Table 128 Latin America: Antibody Development Market, By Type, 2016–2023 (USD Million)
Table 129 Latin America: Custom Antibodies Market, By Type, 2016–2023 (USD Million)
Table 130 Latin America: Custom Antibodies Market, By Source, 2016–2023 (USD Million)
Table 131 Latin America: Custom Antibodies Market, By Research Area, 2016–2023 (USD Million)
Table 132 Latin America: Custom Antibodies Market, By End User, 2016–2023 (USD Million)
Table 133 Middle East & Africa: Custom Antibody Market, By Service, 2016–2023 (USD Million)
Table 134 Middle East & Africa: Antibody Development Market, By Type, 2016–2023 (USD Million)
Table 135 Middle East & Africa: Custom Antibodies Market, By Type, 2016–2023 (USD Million)
Table 136 Middle East & Africa: Custom Antibodies Market, By Source, 2016–2023 (USD Million)
Table 137 Middle East & Africa: Custom Antibodies Market, By Research Area, 2016–2023 (USD Million)
Table 138 Middle East & Africa: Custom Antibodies Market, By End User, 2016–2023 (USD Million)
Table 139 Custom Antibodies Market Share, By Key Player, 2017
Table 140 Product and Service Launches, 2015–2018
Table 141 Expansions, 2015–2018
Table 142 Acquisitions, 2015–2018
Table 143 Other Strategies, 2015–2018


List of Figures (36 Figures)

Figure 1 Custom Antibody Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designations, and Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Custom Antibodies Market, By Service, 2018 vs 2023 (USD Million)
Figure 8 Custom Antibodies Market, By Type, 2018 vs 2023 (USD Million)
Figure 9 Custom Antibodies Market, By Source, 2018 vs 2023 (USD Million)
Figure 10 Custom Antibodies Market, By Research Area, 2018 vs 2023 (USD Million)
Figure 11 Custom Antibodies Market, By End User, 2018 vs 2023 (USD Million)
Figure 12 Geographical Snapshot of the Custom Antibodies Market
Figure 13 Quality Concerns Over Catalog Antibodies & the Expanding AB Therapeutics Pipeline to Drive Market Growth
Figure 14 US Dominated the Custom Antibodies Market in 2017
Figure 15 APAC to Register the Highest Growth Rate During the Forecast Period (2018–2023)
Figure 16 Developing Markets to Register A Higher Growth Rate Between 2018 & 2023
Figure 17 Custom Antibodies Market: Drivers, Opportunities, and Challenges
Figure 18 R&D Investments, By Country (USD Billion)
Figure 19 Number of Therapeutic Antibodies Approved for Market Release (2011–2017)
Figure 20 Personalized Medicine Products, 2008–2016
Figure 21 Increasing Focus on ADCS & the Development of Bispecific Antibodies are the Key Market Trends
Figure 22 Antibody Development Services to Dominate the Custom Antibodies Market During the Forecast Period
Figure 23 Recombinant Antibodies Segment is Expected to Witness High Growth During the Forecast Period
Figure 24 Oncology to Dominate the Custom Antibodies Market During the Forecast Period
Figure 25 Pharmaceutical & Biotechnology Companies to Dominate the Custom Antibodies Market During the Forecast Period
Figure 26 Custom Antibodies Market: Geographic Snapshot (2017)
Figure 27 North America: Custom Antibodies Market Snapshot
Figure 28 Europe: Custom Antibodies Market Snapshot
Figure 29 Asia Pacific: Custom Antibodies Market Snapshot
Figure 30 Expansions—Key Growth Strategy Adopted By Market Players From 2015 to October 2018
Figure 31 Thermo Fisher Scientific Inc.: Company Snapshot
Figure 32 Genscript: Company Snapshot
Figure 33 Abcam PLC: Company Snapshot
Figure 34 Merck Group: Company Snapshot
Figure 35 Bio-Rad Laboratories, Inc.: Company Snapshot
Figure 36 Agilent Technologies, Inc.: Company Snapshot

    This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

    Secondary Research

    Secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Business, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the custom antibody market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, industry experts from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Industry experts from the supply side include CEOs, vice presidents, marketing and sales directors, business development managers, and innovation directors of companies offering custom antibody services, key opinion leaders, and suppliers and distributors, whereas, the industry experts from the demand side include directors of life science companies, research institutes, academic institutes, and related key executives.

    A breakdown of the primary respondents is provided below:

    Custom Antibody Market

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by service, type, research area, end user, and region).

    Data Triangulation

    After arriving at the market size, the total custom antibody market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.

    Objectives of the Study

    • To define, describe, segment, and forecast the custom antibodies market by service, type, source, research area, end user, and region
    • To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
    • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the custom antibodies market in five main regions North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa (along with major countries)
    • To profile key players in the custom antibodies market and comprehensively analyze their core competencies2 and market shares
    • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, partnerships, agreements, and R&D activities of the leading players in the custom antibodies market

    Scope of the Report:


    Report Metric

    Details

    Market size available for years

    2016–2023

    Base year considered

    2017

    Forecast period

    2018–2023

    Forecast units

    Value (USD)

    Segments covered

    Service, Type, Source, Research Area, End User, and  Region

    Geographies covered

    North America, Europe, APAC, Latin America, Middle East, and Africa.

    Companies covered

    Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck Group (Germany), Abcam plc (UK), Cell Signaling Technology, Inc. (US), Agilent Technologies, Inc. (US), GenScript (US), BioLegend, Inc. (US), Rockland Immunochemicals (US), ProMab Biotechnologies (US), Innovagen AB (Sweden), and ProteoGenix (US).

    The research report categorizes the market into the following segments and subsegments:

    Custom Antibody Market, By Service

    • Antibody Development
      • Antigen Preparation
      • Immunization & Hybridoma Production
      • Antibody Characterization
    • Antibody Production & Purification
    • Antibody Fragmentation & Labelling

    Custom Antibody Market, By Type

    • Monoclonal Antibodies
    • Polyclonal Antibodies
    • Recombinant Antibodies
    • Others (Monospecific and Site-specific Antibodies)

    Custom Antibody Market, By Source

    • Mice
    • Rabbit
    • Other Sources (Chickens, Goats, Rats, Pigs, Hamsters, Donkeys, Sheep, Horses, and Cell Cultures)

    Custom Antibody Market, By Research Area

    • Oncology
    • Infectious Diseases
    • Immunology
    • Neurobiology
    • Stem Cell
    • Cardiovascular Diseases
    • Others (Toxicology, Cell Division & Metabolism, Developmental Biology, and Signal Transduction)

    Custom Antibody Market, By End User

    • Pharmaceutical & Biotechnology Companies
    • Academic & Research Institutes
    • Contract Research Organizations

    Custom Antibody Market, by Region

    • North America
      • US
      • Canada
    • Europe
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • Latin America
    • Middle East and Africa

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Company Information

    • Detailed analysis and profiling of additional market players

    Geographic Analysis

    • Further breakdown of the Rest of Asia Pacific custom antibodies market into South Korea, Australia, New Zealand, and other countries
    • Further breakdown of the Latin American custom antibodies market into Brazil, Mexico, and other countries
    Report Code
    BT 6817
    Published ON
    Dec, 2018
    Choose License Type
    BUY NOW
    • SHARE
    X
    Request Customization
    Speak to Analyst
    Speak to Analyst
    OR FACE-TO-FACE MEETING
    PERSONALIZE THIS RESEARCH
    • Triangulate with your Own Data
    • Get Data as per your Format and Definition
    • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
    • Any level of Personalization
    REQUEST A FREE CUSTOMIZATION
    LET US HELP YOU!
    • What are the Known and Unknown Adjacencies Impacting the Custom Antibody Market
    • What will your New Revenue Sources be?
    • Who will be your Top Customer; what will make them switch?
    • Defend your Market Share or Win Competitors
    • Get a Scorecard for Target Partners
    REQUEST A FREE WORKSHOP
    ADJACENT MARKETS
    REQUEST BUNDLE REPORTS
    ONLINE CHAT
    +1-888-600-6441
    • Call Us
    • +1-888-600-6441 (Corporate office hours)
    • +1-888-600-6441 (US/Can toll free)
    • +44-800-368-9399 (UK office hours)
    CONNECT WITH US
    ABOUT TRUST ONLINE
    © MarketsandMarkets Research Private Ltd. All rights reserved
    ...

    Digital Virtual Assistant - MarketsandMarkets

    ...

    Digital Virtual Assistant - MarketsandMarkets

    Home